中孕期预测不良围产期结局
本研究为前瞻性观察性队列研究,纳入40 241例单胎妊娠孕妇,于19+0至23+6周行常规产检,采用竞争风险模型基于母体因素、胎儿估重Z评分及子宫动脉搏动指数中位数倍数评估早产小于胎龄儿风险并分层。结果显示,中孕期评估的SGA高风险孕妇不良新生儿结局风险亦增加,出生体重与不良结局发生率呈连续关联且受分娩孕周影响。
要点
- 中孕期SGA风险分层最高层(>1/4)的NNU入住率≥48h为31.9%,最低层(≤1/100)为5.6%。
- 出生体重低于第1百分位的新生儿NNU入住率≥48h最高(25.7%),随体重百分位升高逐渐降低。
- 早产SGA<第10百分位新生儿NNU入住率≥48h为48.7%,高于早产非SGA的40.9%(P<0.001)。
核心结论
- 出生体重与不良新生儿结局发生率呈连续关联,且受分娩孕周影响;中孕期评估的SGA高风险妊娠亦是不良新生儿结局风险增加的人群。
研究设计与样本
- 前瞻性观察性队列研究,纳入40 241例单胎妊娠孕妇,于19+0至23+6周行常规医院产检;采用竞争风险模型结合母体因素、超声估重Z评分及子宫动脉搏动指数中位数倍数评估早产SGA<第10百分位的妊娠特异性风险,并将人群分为六层风险类别。
诊断标准与关键数值
- 风险分层为>1/4、>1/10至≤1/4、>1/30至≤1/10、>1/50至≤1/30、>1/100至≤1/50及≤1/100;NNU入住≥48h发生率在>1/4层最高为31.9%(95%CI 26.9-36.9%),在≤1/100层最低为5.6%(95%CI 5.3-5.9%);出生体重低于第1百分位者NNU入住≥48h发生率为25.7%(95%CI 23.0-28.5%),第25至<75百分位区间为5.4%(95%CI 5.1-5.7%)。
临床应用与阅片要点
- 中孕期基于竞争风险模型的SGA风险分层可用于识别不良新生儿结局风险增加的人群;风险分层越高,NNU入住≥48h发生率越高,报告时可结合出生体重百分位与分娩孕周综合评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: First, to investigate the association between adverse neonatal outcomes and birth weight and gestational age at delivery. Second, to describe the distribution of adverse neonatal outcomes within different risk strata derived by a population stratification scheme based on the midgestation risk assessment for small-for-gestational-age (SGA) neonates using a competing-risks model.
METHODS: This was a prospective observational cohort study in women with a singleton pregnancy attending a routine hospital visit at 19 + 0 to 23 + 6 weeks' gestation. The incidence of neonatal unit (NNU) admission for ≥ 48 h was evaluated within different birth-weight-percentile subgroups. The pregnancy-specific risk of delivery with SGA < 10th percentile at < 37 weeks was estimated by the competing-risks model for SGA, combining maternal factors and the likelihood functions of Z-score of sonographically estimated fetal weight and uterine artery pulsatility index multiples of the median. The population was stratified into six risk categories: > 1 in 4, > 1 in 10 to ≤ 1 in 4, > 1 in 30 to ≤ 1 in 10, > 1 in 50 to ≤ 1 in 30, > 1 in 100 to ≤ 1 in 50 and ≤ 1 in 100. The outcome measures were admission to the NNU for a minimum of 48 h, perinatal death and major neonatal morbidity. The incidence of each adverse outcome was estimated in each risk stratum.
RESULTS: In the study population of 40 241 women, 0.8%, 2.5%, 10.8%, 10.2%, 19.0% and 56.7% were in the risk strata > 1 in 4, > 1 in 10 to ≤ 1 in 4, > 1 in 30 to ≤ 1 in 10, > 1 in 50 to ≤ 1 in 30, > 1 in 100 to ≤ 1 in 50 and ≤ 1 in 100, respectively. Women in higher-risk strata were more likely to deliver a baby that suffered an adverse outcome. The incidence of NNU admission for ≥ 48 h was highest in the > 1 in 4 risk stratum (31.9% (95% CI, 26.9-36.9%)) and it gradually decreased until the ≤ 1 in 100 risk stratum (5.6% (95% CI, 5.3-5.9%)). The mean gestational age at delivery in SGA cases with NNU admission for ≥ 48 h was 32.9 (95% CI, 32.2-33.7) weeks for risk stratum > 1 in 4 and progressively increased to 37.5 (95% CI, 36.8-38.2) weeks for risk stratum ≤ 1 in 100. The incidence of NNU admission for ≥ 48 h was highest for neonates with birth weight below the 1st percentile (25.7% (95% CI, 23.0-28.5%)) and decreased progressively until the 25th to < 75th percentile interval (5.4% (95% CI, 5.1-5.7%)). Preterm SGA neonates < 10th percentile had significantly higher incidence of NNU admission for ≥ 48 h compared with preterm non-SGA neonates (48.7% (95% CI, 45.0-52.4%) vs 40.9% (95% CI, 38.5-43.3%); P < 0.001). Similarly, term SGA neonates < 10th percentile had significantly higher incidence of NNU admission for ≥ 48 h compared with term non-SGA neonates (5.8% (95% CI, 5.1-6.5%) vs 4.2% (95% CI, 4.0-4.4%); P < 0.001).
CONCLUSIONS: Birth weight has a continuous association with the incidence of adverse neonatal outcomes, which is affected by gestational age. Pregnancies at high risk of SGA, estimated at midgestation, are also at increased risk for adverse neonatal outcomes. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Papastefanou I, Gyokova E, Gungil B, et al. Prediction of adverse perinatal outcome at midgestation. Ultrasound Obstet Gynecol. 2023. PMID: 37289959. doi:10.1002/uog.26285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。